Welcome to the Cores

Testimonials

“University of Massachusetts Chan Medical School core facility services have been extremely critical for in vitro verification of our in silico predicted antiviral small molecule compounds. These core facilities provide a significant advantage for Massachusetts based leading bio-tech companies like ARIScience.” 

 ~ Joy Alamgir, Founder, ARIScience ~

“Rectify Pharmaceuticals has been consistently impressed with the quality and expertise provided by the UMass Chan Medical CryoEM Facility. Their state-of-the-art equipment and knowledgeable staff have been instrumental in advancing our drug discovery efforts. We highly recommend this facility to any company needing advanced cryo-electron microscopy services.”

 ~ Anna Welland, Associate Director, Program Management, Rectify Pharma ~

“At the UMass Chan Core Facilities, it is possible to find any instrument to perform your experiments as well as resourceful scientists to troubleshoot issues and prepare appropriate samples for gathering the best possible results. In addition to the wide variety of instruments and talented staff, we were also able to utilize the UMASS Voucher Program. Our funding sources were tight, and if it were not for these vouchers, we would not be able to do the systematic study we needed to do solid science and achieve our company's milestones. These vouchers are essential for small companies getting off the ground to obtain the data they need to demonstrate feasibility and secure further fundings.” 

~ Lina Gonzales, Founder, SpadXTech, LLC ~

“We have used the UMass Vector Core to produce small-scale recombinant adeno-associated vector preparations for 12 years. These AAV vector preparations have supported early proof of concept studies for multiple programs.  The Vector Core team has provided exceptional service and high quality AAV vector in a timely manner."

~ Denise Woodcock, Sr. Scientist, Vector Production & Gene Therapy, Sanofi ~

"The cryo-EM facility at UMass Chan is by far the best user facility I have ever experienced! The staff is professional, extremely knowledgeable and helpful and collect data of the highest quality in an efficient manner."

~ Fitzpatrick Lab, Zuckerman Institute, Columbia University ~

"We have been impressed with the professionalism and the high quality of data and individuals we have interacted with in the UMass Chan core facilities.  We routinely work with many different CROs in the US and abroad.  The UMass Chan groups we have worked with truly viewed projects as collaborations and worked in an integrated fashion with our semi-virtual company.  They clearly understand and know how to work with small biotechs.  The expertise and services provided were timely and cost effective.  The results and interpretation were reliable and showed an in-depth understanding of the technology and the ability to explain the nuances of data without drowning in details.  I look forward to any future interactions with this group."

~ Mark Tebbe, Co-founder & Chief Technology Officer, Quench Bio ~

"The UMass Chan Core Facilties offer a professional, integrated suite of expert groups with state-of-the-art equipment that, in our experience, has surpassed leading CRO’s for our drug discovery efforts."

"The highly integrated suite of facilities at UMass Chan have surpassed leading CRO’s in cost, speed, and quality for our drug discovery efforts."

"The core facilities at UMass Chan have been an invaluable resource due to their consistent professionalism, experience, and support across both our chemistry and biology efforts."

~ Neil Dhawan, CEO of Fuse Therapeutics ~

---

"We were lucky to have the Mass Spec Core Facility so close to us.  Dr. Shaffer and his group were very interested in our project, we brainstormed together on the best ways to develop the LC/MS assay that we needed, and they proposed a couple of creative approaches to tackle the problem.  Their workplans were well organized in logical stages and had clear objectives for each step.  Once the results began coming in, the staff provided useful summaries and were available for in-person meetings to discuss the data and to plan the next steps.  The project was a success and we now have two potential assays that we can transfer to a GMP laboratory to facilitate release of our preventive HIV vaccine for the next clinical trial.  It's been a great pleasure to work with this team and we will go back to them the next time we need help with any Mass Spec-based projects!"

 ~ Yegor Voronin, COO of Worcester HIV Vaccine ~

"A key challenge for a biotech startup is access to infrastructure and personnel which can be difficult in the early phase of company building since funds are limited.  The UMass Chan core facilities provide valuable means to solve this problem by providing cost-effective access to a wide range of services including cutting edge technologies, high-end instrumentation and technical support for basic, translational and clinical research.  Specifically, my company Ankaa Therapeutics has been able to tap into the small molecule drug discovery, proteomics and structure-based drug design core facilities to be able to access valuable infrastructure and personnel. This has enabled our Company to be capital efficient while building out its' platform which will then enable us to better seek additional financing to build the company."

~ Juswinder Singh, Founder and Chief Scientific Officer - Ankaa Therapeutics ~